Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xin Aoxing Oleanolic Acid Capsule is an over-the-counter Chinese pharmaceutical product containing oleanolic acid, developed and marketed for the treatment of chronic hepatitis B. It is produced by Biostar Pharmaceuticals via its Aoxing Pharmaceutical subsidiary and is positioned as a hepatoprotective and antiviral traditional Chinese medicine–derived formulation aimed at improving liver function and reducing hepatitis B–related symptoms.[1][5][11] Oleanolic acid is a pentacyclic triterpenoid found in many plants and is commonly used in China in liver-protective preparations, where it is thought to exert hepatoprotective, anti-inflammatory, and possible antiviral effects, although its precise molecular targets and mechanism in hepatitis B remain poorly defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xin Aoxing Oleanolic Acid Capsule.